• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.

作者信息

Ribera Josep-María, García Olga, Fernández-Abellán Pascual, Lavilla Esperanza, Bernal María-Teresa, González-Campos José, Brunet Salut, Monteserín María-Carmen, Montesinos Pau, Sarrá Josep, Calbacho Maria, Alvarez-Larrán Alberto, Tormo Mar, Oriol Albert

出版信息

Br J Haematol. 2012 Nov;159(4):485-8. doi: 10.1111/bjh.12043. Epub 2012 Sep 12.

DOI:10.1111/bjh.12043
PMID:22966847
Abstract
摘要

相似文献

1
Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.在酪氨酸激酶抑制剂时代，费城染色体对老年急性淋巴细胞白血病患者无负面影响：两项前瞻性平行方案的比较
Br J Haematol. 2012 Nov;159(4):485-8. doi: 10.1111/bjh.12043. Epub 2012 Sep 12.
2
Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance.酪氨酸激酶抑制剂疗法或用于费城染色体阳性急性淋巴细胞白血病患儿的移植：权衡利弊
Lancet Haematol. 2018 Dec;5(12):e606-e607. doi: 10.1016/S2352-3026(18)30181-9.
3
[Acute lymphoblastic leukemia].[急性淋巴细胞白血病]
Rinsho Ketsueki. 2014 Feb;55(2):185-90.
4
[Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome-positive acute lymphoblastic leukemia].酪氨酸激酶抑制剂达沙替尼联合化疗治疗儿童费城染色体阳性急性淋巴细胞白血病的疗效与安全性
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Jun;17(6):634-7.
5
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.BCR-ABL酪氨酸激酶特异性抑制剂在伴有费城染色体的慢性髓性白血病急变期和急性淋巴细胞白血病中的活性
N Engl J Med. 2001 Apr 5;344(14):1038-42. doi: 10.1056/NEJM200104053441402.
6
Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide.费城染色体阳性的晚期急性淋巴细胞白血病患者在接受酪氨酸激酶抑制剂治疗后复发：对氯法拉滨和环磷酰胺治疗反应良好。
Haematologica. 2009 Oct;94(10):1471-3. doi: 10.3324/haematol.2009.011718. Epub 2009 Jul 16.
7
Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.费城染色体阳性急性淋巴细胞白血病
Hematology. 2015 Dec;20(10):618-9. doi: 10.1179/1024533215Z.000000000402.
8
Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives.Ph+急性淋巴细胞白血病中的酪氨酸激酶抑制剂：现状与展望
Ann Hematol. 2016 Apr;95(5):681-93. doi: 10.1007/s00277-016-2617-y. Epub 2016 Feb 19.
9
Moving away from chemotherapy in newly diagnosed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia.新诊断的费城染色体阳性 B 细胞急性淋巴细胞白血病中逐步减少化疗。
Br J Haematol. 2023 Sep;202(6):1084-1086. doi: 10.1111/bjh.19012. Epub 2023 Jul 31.
10
[Successful induction and long-term molecular remission with imatinib mesylate and chemotherapy in a case of Ph-positive acute lymphoblastic leukemia].[甲磺酸伊马替尼与化疗联合治疗Ph阳性急性淋巴细胞白血病1例获成功诱导及长期分子学缓解]
Rinsho Ketsueki. 2003 May;44(5):334-8.

引用本文的文献

1
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.通过对基因组 DNA 的超高深度测序检测 BCR::ABL1 白血病中的激酶结构域突变。
Sci Rep. 2022 Jul 29;12(1):13057. doi: 10.1038/s41598-022-17271-3.
2
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia.老年（>55岁）急性淋巴细胞白血病患者的特征与预后
Cancers (Basel). 2022 Jan 23;14(3):565. doi: 10.3390/cancers14030565.
3
Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy?
老年人急性淋巴细胞白血病：传统化疗的终章？
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):7-14. doi: 10.1182/hematology.2021000226.
4
Targeted Therapy in Acute Lymphoblastic Leukaemia.急性淋巴细胞白血病的靶向治疗
J Pers Med. 2021 Jul 25;11(8):715. doi: 10.3390/jpm11080715.
5
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.BCR-ABL1阳性急性淋巴细胞白血病中枢神经系统复发患者的临床特征：脑脊液中ABL1突变特征分析的重要性
Ann Hematol. 2017 Jul;96(7):1069-1075. doi: 10.1007/s00277-017-3002-1. Epub 2017 Apr 27.
6
translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors.在强效酪氨酸激酶抑制剂时代，易位作为老年急性淋巴细胞白血病患者的一个有利预后因素。
Haematologica. 2017 May;102(5):e187-e190. doi: 10.3324/haematol.2016.159988. Epub 2017 Jan 12.
7
Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine.治疗复发或难治性费城染色体阴性急性淋巴细胞白血病：脂质体包裹长春新碱。
Int J Nanomedicine. 2013;8:3479-88. doi: 10.2147/IJN.S47037. Epub 2013 Sep 16.